New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis ; volume:24 ; number:1 ; day:6 ; month:6 ; year:2024 ; pages:1-11 ; date:12.2024
BMC cancer ; 24, Heft 1 (6.6.2024), 1-11, 12.2024
- Creator
-
Xu, Jing-Xuan
Zhu, Qi-Long
Bi, Yu-Miao
Peng, Yu-Chong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-12453-w
- URN
-
urn:nbn:de:101:1-2408132111175.789867859029
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xu, Jing-Xuan
- Zhu, Qi-Long
- Bi, Yu-Miao
- Peng, Yu-Chong
- SpringerLink (Online service)
Other Objects (12)
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Metformin as adjuvant therapy for glioma
Common Methods for Performing Mendelian Randomization
Mendelian Randomization and Type 2 Diabetes
Recent Developments in Mendelian Randomization Studies
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Metformin as adjuvant therapy for glioma
Common Methods for Performing Mendelian Randomization
Mendelian Randomization and Type 2 Diabetes
Recent Developments in Mendelian Randomization Studies
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Metformin as adjuvant therapy for glioma
Common Methods for Performing Mendelian Randomization
Mendelian Randomization and Type 2 Diabetes